6 results match your criteria: "3825 Bay Center Place[Affiliation]"
Biotechnol Prog
January 2006
Department of Process Science, Kosan Biosciences, Inc., 3825 Bay Center Place, Hayward, CA 94545, USA.
Epothilone D is a member of a class of potent antineoplastic natural products produced by myxobacteria. Previously, we have described a fed-batch epothilone D production process in which an adsorber resin is incorporated into the bioreactor setup to capture and stabilize the product in situ, preventing its degradation within the bioreactor. The capture of epothilone D by these relatively large resin beads enables the development of continuous and semicontinuous culturing systems incorporating bead retention mechanisms to completely retain the product within the bioreactor, increasing the epothilone D product titer by almost 3-fold in both cases over a baseline fed-batch system.
View Article and Find Full Text PDFBiotechnol Prog
April 2005
Kosan Biosciences, Inc., 3825 Bay Center Place, Hayward, California 94545, USA.
The bioconversion of a 6-deoxyerythronolide B analogue to the corresponding erythromycin A analogue (R-EryA) by a Saccharopolyspora erythraea mutant lacking the ketosynthase in the first polyketide synthase module was significantly improved by changing fluxes at a key branch point affecting the erythromycin congener distribution. This was achieved by integrating an additional copy of the eryK gene into the chromosome under control of the eryAIp promoter. Real-time PCR analysis of RNA confirmed higher expression of eryK in the resulting strain, S.
View Article and Find Full Text PDFMol Ther
June 2002
Gencell, Aventis Pharma, 3825 Bay Center Place, Hayward, California 94545, USA.
Nonviral systemic delivery is one of the most attractive approaches for cancer gene therapy. To achieve this goal, various laboratories have developed cationic liposomes. However, when injected intravenously, cationic lipid-DNA complexes accumulate mostly into and transfect lung tissue.
View Article and Find Full Text PDFGene
November 2001
Gencell, a division of Aventis Pharma, 3825 Bay Center Place, Hayward, CA 94545, USA.
The improvement of gene therapy vectors would benefit from the availability of a reporter gene that can be used for long-term studies in immunocompetent laboratory animals. We describe the construction and characterization of a novel reporter gene, murine secreted embryonic alkaline phosphatase (MUSEAP). We demonstrate by gene transfer in skeletal muscle of immunocompetent mice that MUSEAP is efficiently secreted and detected in the bloodstream and that injection of an increasing dose of DNA leads to a dose-dependent increase of plasma MUSEAP activity.
View Article and Find Full Text PDFAngew Chem Int Ed Engl
December 2000
Aventis Gencell 3825 Bay Center Place Hayward, CA 94545, USA, Fax: (+1) 510-887-1680.